SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20086)5/5/1998 12:08:00 PM
From: bob zagorin  Read Replies (2) | Respond to of 32384
 
another thing that is quite interesting about the entremed story is that the science was published months ago. the stock rise is a media phenomena. the obvious conclusion is to do your own research, draw your own conclusions, take a position and be patient.

that entails a litte more effort than posting one-liners but henry's web site makes it pretty darn easy for those interested in ligand.



To: Henry Niman who wrote (20086)5/5/1998 3:24:00 PM
From: Vector1  Read Replies (1) | Respond to of 32384
 
Henry,
at theú American Society of Clinical Oncology meeting in L.A. on May 19th LGND will present - Phase II Panretin data and Phase I/II LGND 1550 data. Any views on what will be presented.
V1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News